Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,402
Closed -$365K 108
2024
Q4
$365K Buy
1,402
+49
+4% +$14.5K 0.03% 116
2024
Q3
$436K Buy
1,353
+168
+14% +$55K 0.03% 100
2024
Q2
$370K Buy
1,185
+1
+0.1% +$294 0.03% 97
2024
Q1
$337K Buy
1,184
+165
+16% +$48.3K 0.03% 109
2023
Q4
$293K Buy
1,019
+56
+6% +$15.3K 0.03% 92
2023
Q3
$259K Buy
963
+1
+0.1% +$250 0.03% 78
2023
Q2
$214K Sell
962
-18
-2% -$4.18K 0.03% 114
2023
Q1
$237K Buy
980
+20
+2% +$4.91K 0.03% 93
2022
Q4
$252K Hold
960
0.03% 79
2022
Q3
$216K Buy
+960
New +$233K 0.03% 80

Other funds holding AMGN

FFT Wealth Management's AMGN Position: Q1 2025 in Review

FFT Wealth Management sold out of Amgen (AMGN) in Q1 2025, closing a stake of 1,402 shares — an estimated $365K sold.

FFT Wealth Management first reported a position in AMGN in Q3 2022 and held it in 10 quarters. The position peaked at $436K in Q3 2024. 2,926 funds tracked by Wall St. Rank hold AMGN as of Q1 2025.

  • FFT Wealth Management reported no remaining Amgen position as of Q1 2025 after selling out during the quarter.
  • FFT Wealth Management sold 1,402 Amgen shares in Q1 2025, an estimated $365K.
  • FFT Wealth Management first reported a position in Amgen in Q3 2022 and held it in 10 quarters.
  • FFT Wealth Management's Amgen position peaked at $436K in Q3 2024.
  • 2,926 funds tracked by Wall St. Rank held Amgen as of Q1 2025.

Based on FFT Wealth Management's 13F filing for Q1 2025, filed 15 May 2025.